1H-Imidazo[4,5-c]quinolin-4-amine, 1-[[4-(aminomethyl)phenyl]methyl]-2-butyl- HCL manufacturers
- TLR7/8 agonist 1
-
- $48.00
-
2026-07-31
- CAS:1258457-59-8
- Purity: 99.50%
- Supply Ability: 10g
|
| | 1H-Imidazo[4,5-c]quinolin-4-amine, 1-[[4-(aminomethyl)phenyl]methyl]-2-butyl- HCL Basic information |
| Product Name: | 1H-Imidazo[4,5-c]quinolin-4-amine, 1-[[4-(aminomethyl)phenyl]methyl]-2-butyl- HCL | | Synonyms: | 1H-Imidazo[4,5-c]quinolin-4-amine, 1-[[4-(aminomethyl)phenyl]methyl]-2-butyl- HCL;1-(4-(aminomethyl)benzyl)-2-butyl-1H-imidazo[4,5-c]quinolin-4-ylamine;1H-Imidazo[4,5-c]quinolin-4-amine, 1-[[4-(aminomethyl)phenyl]methyl]-2-butyl-;1-(4-(aminomethyl)benzyl)-2-butyl-1H-imidazo[4,5-c]quinolin-4-amine hydrochloride;1-[[4-(aminomethyl)phenyl]methyl]-2-butyl-1H-imidazo[4,5-c]quinolin-4-amine;1-[[4-(Aminomethyl)phenyl]methyl]-2-Butyl-Imidazo[4,5-C]quinolin-4-Amine;TLR7/8 agonist 7d;1-(4-(aminomethyl)benzyl)-2-butyl-1H-imidazolebenzo[4,5-c]quinoline-4-amine | | CAS: | 1258457-59-8 | | MF: | C22H25N5 | | MW: | 359.47 | | EINECS: | | | Product Categories: | | | Mol File: | 1258457-59-8.mol | ![1H-Imidazo[4,5-c]quinolin-4-amine, 1-[[4-(aminomethyl)phenyl]methyl]-2-butyl- HCL Structure](CAS/20200611/GIF/1258457-59-8.gif) |
| | 1H-Imidazo[4,5-c]quinolin-4-amine, 1-[[4-(aminomethyl)phenyl]methyl]-2-butyl- HCL Chemical Properties |
| Boiling point | 633.3±55.0 °C(Predicted) | | density | 1.25±0.1 g/cm3(Predicted) | | pka | 9.06±0.10(Predicted) | | form | Solid | | color | Off-white to light yellow | | InChI | InChI=1S/C22H25N5/c1-2-3-8-19-26-20-21(17-6-4-5-7-18(17)25-22(20)24)27(19)14-16-11-9-15(13-23)10-12-16/h4-7,9-12H,2-3,8,13-14,23H2,1H3,(H2,24,25) | | InChIKey | SDSKFWHQCNBICO-UHFFFAOYSA-N | | SMILES | N1C2C(=CC=CC=2)C2N(CC3=CC=C(CN)C=C3)C(CCCC)=NC=2C=1N |
| | 1H-Imidazo[4,5-c]quinolin-4-amine, 1-[[4-(aminomethyl)phenyl]methyl]-2-butyl- HCL Usage And Synthesis |
| Uses | TLR7/8 agonist 1 is a toll-like receptor (TLR7)/TLR8 dual-agonistic imidazoquinoline. | | IC 50 | TLR7; TLR8 | | References | [1] Shukla NM, et al. Syntheses of fluorescent imidazoquinoline conjugates as probes of Toll-like receptor 7. Bioorg Med Chem Lett. 2010 Nov 15;20(22):6384-6. DOI:10.1016/j.bmcl.2010.09.093 [2] Beesu M, et al. Structure-Based Design of Human TLR8-Specific Agonists with Augmented Potency and Adjuvanticity. J Med Chem. 2015 Oct 8;58(19):7833-49. DOI:10.1021/acs.jmedchem.5b01087 |
| | 1H-Imidazo[4,5-c]quinolin-4-amine, 1-[[4-(aminomethyl)phenyl]methyl]-2-butyl- HCL Preparation Products And Raw materials |
|